Preference values associated with stage III colon cancer and adjuvant chemotherapy
β Scribed by Jennie H. Best; Louis P. Garrison; William Hollingworth; Scott D. Ramsey; David L. Veenstra
- Book ID
- 106510467
- Publisher
- Springer Netherlands
- Year
- 2010
- Tongue
- English
- Weight
- 192 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0962-9343
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
I n their article regarding the timing of adjuvant chemotherapy in patients with colon cancer, Hershman et al. 1 stated that the effect of the interval between surgery and the beginning of adjuvant chemotherapy has not been investigated to date. However, to our knowledge, there are at least 3 public
## Abstract ## BACKGROUND. An important advance in medical oncology has been the use of adjuvant chemotherapy for lymph nodeβpositive colon cancer. However, to the authors' knowledge, the effect of the interval between surgery and the initiation of chemotherapy on survival has not been investigate
## Abstract Maspin, a member of the Serpin protease inhibitor family, is overexpressed in poorly differentiated colorectal tumors and more frequently found in tumors with microsatellite instability. Immunohistochemical nuclear Maspin staining is predominantly seen in tumor cells at the invasion fro